Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: The Scientific Basis of Rheumatology

Review

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

Hideaki Nagase* and Keith Brew

Arthritis Res 2002, 4(Suppl 3):S51-S61 doi:10.1186/ar573


London, UK. 24-26 June 2002

No comments have yet been made on this article.

Post a comment